封面
市场调查报告书
商品编码
1672977

细胞冷冻保存市场按产品类型、应用、最终用户和地区划分

Cell Cryopreservation Market, By Product Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 192 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2025 年全球细胞冷冻保存市场规模将达到 124.4 亿美元,到 2032 年预计将达到 536.4 亿美元,2025 年至 2032 年的复合年增长率为 23.2%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 124.4亿美元
效能资料 2020-2024 预测期 2025-2032
预测期:2025 年至 2032 年复合年增长率 23.20% 2032 年金额预测 536.4亿美元
数字。 2025 年细胞冷冻保存市场占有率(按地区划分)
细胞冷冻保存市场-IMG1

细胞冷冻保存是使用液态氮将细胞冷却至极低温度(通常低于 -80°C)来保存细胞。细胞可以保存很长一段时间而不会影响细胞活力。癌症和遗传疾病的增加,再生医学研究、干细胞库、生育治疗和组织工程的投资增加等因素可能会推动研究机构和医院对细胞冷冻保存过程的需求。冷冻保存设备和解决方案的技术进步也推动了市场的成长。然而,与冷冻保存程序和设备相关的高成本可能会在预测期内阻碍市场的成长。

市场动态

全球细胞冷冻保存市场成长的主要驱动力是慢性和危及生命的疾病的发生率不断上升。癌症和遗传疾病的全球蔓延推动了对严重依赖冷冻保存细胞的研究活动、细胞疗法和临床测试的需求。根据世界癌症研究基金会的数据,2020 年全球将报告约 1,800 万例新发癌症病例。此外,公共和私人对再生医学、干细胞研究和医学生物技术创新的投资不断增加,也正在推动冷冻保存流程的普及。然而,冷冻保存设备、液态氮和整体程序的高成本可能会阻碍市场的成长。此外,熟练专业人员的短缺和耗时的冷冻过程中的技术挑战也可能阻碍市场的成长。机器人冷冻保存技术和设备的不断发展可能会提供有利可图的市场成长机会。

本研究的主要特点

  • 本报告对全球细胞冷冻保存市场进行了详细分析,并提供了预测期(2025-2032)的市场规模和年复合成长率(CAGR%),假设 2024 年为基准年。
  • 它还揭示了各个领域的潜在商机,并解释了该市场的有吸引力的投资提案矩阵。
  • 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
  • 全球细胞冷冻保存市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球细胞冷冻保存市场报告涉及该行业的各个相关人员,例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员可以透过全球细胞冷冻保存市场分析中使用的各种策略矩阵来促进他们的决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • 一致的机会图 (COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 监管情景
  • 收购和合作场景
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第四章 全球细胞冷冻保存市场-冠状病毒 (COVID-19) 大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 市场影响

5. 2020-2032 年全球细胞冷冻保存市场(按产品类型划分)(十亿美元)

  • 介绍
  • 防冻液
  • 甘油
  • 二甲基亚砜(DMSO)
  • 其他的
  • 装置
  • 培养箱
  • 液态液态氮供给罐
  • 冷冻库
  • 其他的

6. 2020-2032 年全球细胞冷冻保存市场(按应用划分)(十亿美元)

  • 介绍
  • 干细胞
  • 卵子和生殖细胞
  • 精子细胞
  • 肝细胞
  • 其他的

7. 2020-2032 年全球细胞冷冻保存市场(按最终用户划分)(十亿美元)

  • 介绍
  • 生物製药和製药公司
  • 研究所
  • 生物库
  • 试管婴儿诊所
  • 其他的

8. 2020 年至 2032 年全球细胞冷冻保存市场(按地区划分)(单位:十亿美元)

  • 介绍
  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第九章 竞争格局

  • 公司简介
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • GE Healthcare
    • Lonza Group Ltd.
    • STEMCELL Technologies Inc.
    • BioLife Solutions, Inc.
    • Cryolife, Inc.
    • Organ Recovery Systems Inc.
    • Custom Biogenic Systems
    • Sartorius AG
    • Takara Bio Inc.
    • Chart Industries, Inc.
    • Biocision, LLC
    • Cardinal Health, Inc.
    • Helmer Scientific

第 10 章分析师建议

  • 兴衰
  • 一致的机会地图

第 11 章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI1698

Global Cell Cryopreservation Market is estimated to be valued at USD 12.44 Bn in 2025 and is expected to reach USD 53.64 Bn by 2032, growing at a compound annual growth rate (CAGR) of 23.2% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 12.44 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 23.20% 2032 Value Projection: USD 53.64 Bn
Figure. Cell Cryopreservation Market Share (%), By Region 2025
Cell Cryopreservation Market - IMG1

Cell cryopreservation involves preserving cells by cooling them to extremely low temperatures, usually -80°C or below using liquid nitrogen. It helps to preserve cells for a very long period of time without affecting their viability. Factors such as rising prevalence of cancers and genetic disorders, increasing investments in regenerative medicine research, stem cell banking, fertility preservation and tissue engineering can boost demand for cell cryopreservation processes across research institutes and hospitals. Technological advancements in cryopreservation equipment and solutions can also drive the market growth. However, high costs associated with cryopreservation procedures and equipment can hamper the market growth during the forecast period.

Market Dynamics:

Global cell cryopreservation market growth is mainly driven by rising incidence of chronic and life-threatening diseases. Growing prevalence of cancers and genetic disorders globally boosts demand for research activities, cell therapies and clinical trials which heavily rely on cryopreserved cells. According to the World Cancer Research Fund, approximately 18 million new cancer cases were reported globally in 2020. Furthermore, increasing investments by both public and private players in regenerative medicine, stem cell research and medical biotech innovations have also boosted the uptake of cryopreservation processes. However, high costs associated with cryopreservation equipment, liquid nitrogen and overall procedures can hamper the market growth. Lack of skilled professionals and technical challenges during slow freezing processes can also hamper the market growth. Ongoing developments in robotic cryostorage technologies and equipment can offer lucrative market growth opportunities.

Key Features of the Study:

  • This report provides in-depth analysis of the global cell cryopreservation market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cell cryopreservation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, AMS Biotechnology (Europe) Limited, Nippon Genetics, Miltenyi Biotec, Mediatech, Inc., Genzyme Corporation, BioLifeSolutions, Inc., VWR International, LLC, and BiolifeSolutions, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global cell cryopreservation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell cryopreservation market

Detailed Segmentation-

  • By Product Type
    • Cryoprotectant Agents
    • Glycerol
    • Dimethyl Sulfoxide (DMSO)
    • Others
    • Equipment
    • Incubators
    • Liquid Nitrogen Supply Tanks
    • Freezers
    • Others
  • By Application
    • Stem Cells
    • Oocytes and Embryotic cells
    • Sperm Cells
    • Hepatocytes
    • Others
  • By End User
    • Biopharmaceutical & Pharmaceutical Companies
    • Research Institutes
    • Biobanks
    • IVF clinics
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • GE Healthcare
    • Lonza Group Ltd.
    • STEMCELL Technologies Inc.
    • BioLife Solutions, Inc.
    • Cryolife, Inc.
    • Organ Recovery Systems Inc.
    • Custom Biogenic Systems
    • Sartorius AG
    • Takara Bio Inc.
    • Chart Industries, Inc.
    • Biocision, LLC
    • Cardinal Health, Inc.
    • Helmer Scientific

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Cell Cryopreservation Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Cell Cryopreservation Market, By Product Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cryoprotectant Agents
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Glycerol
  • Dimethyl Sulfoxide (DMSO)
  • Others
  • Equipment
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Incubators
  • Liquid Nitrogen Supply Tanks
  • Freezers
  • Others

6. Global Cell Cryopreservation Market, By Application, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Stem Cells
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Oocytes and Embryotic cells
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Sperm Cells
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Hepatocytes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Cell Cryopreservation Market, By End User, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Biopharmaceutical & Pharmaceutical Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Research Institutes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Biobanks
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • IVF clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Cell Cryopreservation Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Thermo Fisher Scientific Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Merck KGaA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GE Healthcare
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Lonza Group Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • STEMCELL Technologies Inc.
    • BioLife Solutions, Inc.
    • Cryolife, Inc.
    • Organ Recovery Systems Inc.
    • Custom Biogenic Systems
    • Sartorius AG
    • Takara Bio Inc.
    • Chart Industries, Inc.
    • Biocision, LLC
    • Cardinal Health, Inc.
    • Helmer Scientific

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact